Menü Kapat

Evaluation of ceftazidime-avibactam efficacy in gram negative bacteria

Orjinal Article

Evaluation of ceftazidime-avibactam efficacy in gram negative bacteria

Receiving Date: 09 March 2022

Accept Date: 23 May 2022

Available Online: 08.07.2022

doi: 10.5455/medscience.2022.03.060

Medicine Science 2022;11(3): 1040-3

Conflict of interests: The authors declare that there is no conflict of interest in the study.
Financial Disclosure: The authors declare that they have received no financial support for the study.
Ethical approval: Ethics committee approval is not required for this study.

Table 1. Antibiotic susceptibility results of isolates K. pneumoniae

 3,368 total views,  11 views today

Celikol Y, Atuncekic Yildirim A, Calgin MK. Evaluation of ceftazidime-avibactam efficacy in gram negative bacteria. Med Science. 2022;11(3):1040-3.

⇓ PlumX Meter

Corresponding Author:Yeliz Cetinkol, Afyonkarahisar University of Health Siences Faculty of Medicine, Department of Medical Microbiology, Afyonkarahisar, Turkey.
E-mail: dryelizcetinkol@gmail.com